Free Trial
NASDAQ:CDMO

Avid Bioservices (CDMO) Stock Price, News & Analysis

Avid Bioservices logo
$12.50 +0.02 (+0.12%)
Closing price 02/5/2025
Extended Trading
$12.50 0.00 (0.00%)
As of 02/5/2025 04:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Avid Bioservices Stock (NASDAQ:CDMO)

Key Stats

Today's Range
$12.47
$12.51
50-Day Range
$12.50
$12.50
52-Week Range
$7.22
$12.51
Volume
3.07 million shs
Average Volume
1.45 million shs
Market Capitalization
$799.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.25
Consensus Rating
Hold

Company Overview

Avid Bioservices Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

CDMO MarketRank™: 

Avid Bioservices scored higher than 18% of companies evaluated by MarketBeat, and ranked 867th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Avid Bioservices has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Avid Bioservices has received no research coverage in the past 90 days.

  • Read more about Avid Bioservices' stock forecast and price target.
  • Earnings Growth

    Earnings for Avid Bioservices are expected to grow in the coming year, from ($0.46) to ($0.23) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Avid Bioservices is -5.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Avid Bioservices is -5.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Avid Bioservices has a P/B Ratio of 4.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Avid Bioservices' valuation and earnings.
  • Short Interest

    There is no current short interest data available for CDMO.
  • Dividend Yield

    Avid Bioservices does not currently pay a dividend.

  • Dividend Growth

    Avid Bioservices does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CDMO.
    • Insider Buying vs. Insider Selling

      In the past three months, Avid Bioservices insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 3.05% of the stock of Avid Bioservices is held by insiders.

    • Percentage Held by Institutions

      97.16% of the stock of Avid Bioservices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

    • Read more about Avid Bioservices' insider trading history.
    Receive CDMO Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Avid Bioservices and its competitors with MarketBeat's FREE daily newsletter.

    CDMO Stock News Headlines

    TEHN.BE,0P0000CK2E,0 (TEHN.BE)
    Avid Bioservices launches new company website design
    What Trump Knows About Gold & Why It Matters Now
    Billionaires Love Trump - Is This The Real Reason Why?
    See More Headlines

    CDMO Stock Analysis - Frequently Asked Questions

    Avid Bioservices' stock was trading at $12.35 at the beginning of the year. Since then, CDMO stock has increased by 1.2% and is now trading at $12.4950.

    Avid Bioservices, Inc. (NASDAQ:CDMO) announced its earnings results on Tuesday, December, 10th. The biopharmaceutical company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.13) by $0.14. Avid Bioservices had a negative trailing twelve-month return on equity of 33.18% and a negative net margin of 101.07%.

    Shares of Avid Bioservices reverse split on Monday, July 10th 2017.The 1-7 reverse split was announced on Friday, July 7th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 7th 2017. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

    Shares of CDMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Avid Bioservices investors own include American Water Works (AWK), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY) and Humana (HUM).

    Company Calendar

    Last Earnings
    12/10/2024
    Today
    7/09/2025
    Next Earnings (Estimated)
    9/08/2025
    Fiscal Year End
    4/30/2026

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Pharmaceutical preparations
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:CDMO
    CIK
    704562
    Employees
    320
    Year Founded
    N/A

    Price Target and Rating

    High Price Target
    $12.50
    Low Price Target
    $12.00
    Potential Upside/Downside
    -2.0%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.00
    Research Coverage
    4 Analysts

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$140.75 million
    Net Margins
    -101.07%
    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    $139.91 million
    Cash Flow
    $0.15 per share
    Price / Cash Flow
    80.92
    Book Value
    $3.02 per share
    Price / Book
    4.14

    Miscellaneous

    Free Float
    62,012,000
    Market Cap
    $799.18 million
    Optionable
    Optionable
    Beta
    1.39

    Social Links

    A Beginner's Guide to Investing in Cannabis Cover

    Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

    Get This Free Report

    This page (NASDAQ:CDMO) was last updated on 7/10/2025 by MarketBeat.com Staff
    From Our Partners